Home » Topics » Conferences

Conferences
RSS

Mechanism of action elucidated for anthracycline developed by Sumitomo

Oct. 27, 1997

TOP-53: preclinical antitumor activity and pharmacokinetics

Oct. 27, 1997

MS-209 reverses MDR mediated by MRP and P-glycoprotein

Oct. 24, 1997

Synthetic retinoid with antiangiogenic/apoptosis-inducing effects from Taiho

Oct. 24, 1997

Taiho reports preclinical studies on TAS-103

Oct. 24, 1997

Preclinical studies on TZT-1027, an antitumor dolastatin 10 derivative

Oct. 24, 1997

NCA-0465: new antitumor indoloquinoxaline derivative

Oct. 24, 1997

Cellular target of new antitumor agent from Nippon Shinyaku identified

Oct. 24, 1997

Nikken presents new modulator of multidrug resistance

Oct. 24, 1997

New DC-107 derivative presented at cancer meeting

Oct. 24, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...